Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Functional and Mass Spectrometric Evaluation of an Anti-Tick Antigen Based on the P0 Peptide Conjugated to Bm86 Protein.
Rodríguez Mallón A, Javier González L, Encinosa Guzmán PE, Bechara GH, Sanches GS, Pousa S, Cabrera G, Cabrales A, Garay H, Mejías R, López Álvarez JR, Bello Soto Y, Almeida F, Guirola O, Rodríguez Fernández R, Fuentes Castillo A, Méndez L, Jiménez S, Licea-Navarro A, Portela M, Durán R, Estrada MP. Rodríguez Mallón A, et al. Among authors: cabrales a. Pathogens. 2020 Jun 25;9(6):513. doi: 10.3390/pathogens9060513. Pathogens. 2020. PMID: 32630414 Free PMC article.
Introducing an Asp-Pro linker in the synthesis of random one-bead-one-compound hexapeptide libraries compatible with ESI-MS analysis.
Masforrol Y, Gil J, González LJ, Pérez-Riverol Y, Fernández-de-Cossío J, Sánchez A, Betancourt LH, Garay HE, Cabrales A, Albericio F, Yang H, Zubarev RA, Besada V, Acosta OR. Masforrol Y, et al. Among authors: cabrales a. ACS Comb Sci. 2012 Mar 12;14(3):145-9. doi: 10.1021/co200159r. Epub 2012 Feb 28. ACS Comb Sci. 2012. PMID: 22280455
Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine.
Fernández E, Toledo JR, Méndez L, González N, Parra F, Martín-Alonso JM, Limonta M, Sánchez K, Cabrales A, Estrada MP, Rodríguez-Mallón A, Farnós O. Fernández E, et al. Among authors: cabrales a. PLoS One. 2013;8(2):e56417. doi: 10.1371/journal.pone.0056417. Epub 2013 Feb 27. PLoS One. 2013. PMID: 23460801 Free PMC article.
High efficacy of a 20 amino acid peptide of the acidic ribosomal protein P0 against the cattle tick, Rhipicephalus microplus.
Rodríguez-Mallon A, Encinosa PE, Méndez-Pérez L, Bello Y, Rodríguez Fernández R, Garay H, Cabrales A, Méndez L, Borroto C, Estrada MP. Rodríguez-Mallon A, et al. Among authors: cabrales a. Ticks Tick Borne Dis. 2015 Jun;6(4):530-7. doi: 10.1016/j.ttbdis.2015.04.007. Epub 2015 Apr 28. Ticks Tick Borne Dis. 2015. PMID: 25958782
Monoclonal antibody against Nile tilapia (Oreochromis niloticus) IgM heavy chain: A valuable tool for detection and quantification of IgM and IgM+ cells.
Velázquez J, Rodríguez A, Aragón H, Haidar A, González M, Valdés R, Garay HE, Abreu DD, Ramos Y, Cabrales A, Morales A, González O, Herrera F, Estrada MP, Carpio Y. Velázquez J, et al. Among authors: cabrales a. Fish Shellfish Immunol. 2021 Mar;110:44-54. doi: 10.1016/j.fsi.2020.12.007. Epub 2020 Dec 24. Fish Shellfish Immunol. 2021. PMID: 33348037
Synthesis, LC-MS/MS analysis, and biological evaluation of two vaccine candidates against ticks based on the antigenic P0 peptide from R. sanguineus linked to the p64K carrier protein from Neisseria meningitidis.
González LJ, Encinosa Guzmán PE, Machado W, Pousa S, Leyva A, Arguelles ALC, Cabrera G, Espinosa LA, Parra R, Hernández R, Soto YB, Ledesma FL, Joglar M, Guirola O, Kurt LU, Carvalho PC, Cabrales A, Garay H, Besada V, Durán R, Takao T, Estrada MP, Rodríguez-Mallon A. González LJ, et al. Among authors: cabrales a. Anal Bioanal Chem. 2021 Sep;413(23):5885-5900. doi: 10.1007/s00216-021-03569-0. Epub 2021 Aug 3. Anal Bioanal Chem. 2021. PMID: 34341841 Free PMC article.
Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate.
Ávalos I, Lao T, Rodríguez EM, Zamora Y, Rodríguez A, Ramón A, Lemos G, Cabrales A, Bequet-Romero M, Casillas D, Andújar I, Espinosa LA, González LJ, Alvarez Y, Carpio Y, Estrada MP. Ávalos I, et al. Among authors: cabrales a. Vaccines (Basel). 2022 Jun 3;10(6):897. doi: 10.3390/vaccines10060897. Vaccines (Basel). 2022. PMID: 35746505 Free PMC article.
Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19.
Lao T, Avalos I, Rodríguez EM, Zamora Y, Rodriguez A, Ramón A, Alvarez Y, Cabrales A, Andújar I, González LJ, Puente P, García C, Gómez L, Valdés R, Estrada MP, Carpio Y. Lao T, et al. Among authors: cabrales a. PLoS One. 2023 Sep 26;18(9):e0288006. doi: 10.1371/journal.pone.0288006. eCollection 2023. PLoS One. 2023. PMID: 37751460 Free PMC article.
A first-in-class, first-in-human, phase I trial of CIGB-552, a synthetic peptide targeting COMMD1 to inhibit the oncogenic activity of NF-κB in patients with advanced solid tumors.
Vallespi MG, Mestre B, Marrero MA, Uranga R, Rey D, Lugiollo M, Betancourt M, Silva K, Corrales D, Lamadrid Y, Rodriguez Y, Maceo A, Chaviano PP, Lemos G, Cabrales A, Freyre FM, Santana H, Garay HE, Oliva B, Fernandez JR. Vallespi MG, et al. Among authors: cabrales a. Int J Cancer. 2021 Sep 15;149(6):1313-1321. doi: 10.1002/ijc.33695. Epub 2021 May 27. Int J Cancer. 2021. PMID: 34019700 Free article. Clinical Trial.
37 results